NANOPARTICLES FOR USE IN INCREASING BRAIN WORKING CAPACITY OR IN STRESS TREATMENT Russian patent published in 2022 - IPC A61K33/24 A61K33/38 A61K33/242 A61K33/243 A61K33/244 A61K33/44 A61K9/14 A61K9/16 A61P25/00 A61P43/00 

Abstract RU 2782384 C2

FIELD: medicine.

SUBSTANCE: use of a nanoparticle or an aggregate of nanoparticles and a composition based on them for improvement of training, memorizing, and attention in a subject is disclosed, where material of the nanoparticle or the aggregate of nanoparticles is selected from conductive material selected from Tl, Po, Ag, Pd, Ir, Pt, and/or Au, and organic material having adjacent sp2-hybridized carbon centers in its structure, and insulation material selected from La2O3, SiO2, SnO2, Ta2O5, ReO2, ZrO2, HfO2, Y2O3, and diamond-like carbon, where i) a median size of a core of the nanoparticle or the aggregate of nanoparticles of a population is at least 30 nm, when material is conductive material, where ii) the core of the nanoparticle or the aggregate of nanoparticles is covered with biocompatible coating providing a negative surface charge, where iii) nanoparticles or aggregates of nanoparticles are not used as a carrier of a therapeutic compound or a drug, and where iv) biocompatible coating providing the negative surface charge is selected from phosphate, dicarboxylic acid, succinic acid, or sulphate. The use of the above-described nanoparticles or the aggregate of nanoparticles and the composition based on them for the treatment of at least one symptom of pathological stress is also disclosed.

EFFECT: group of inventions provides treatment of diseases and improvement of conditions without impact on a nanoparticle or an aggregate of nanoparticles of an electric field or any other external activation source.

7 cl, 5 dwg, 3 tbl, 12 ex

Similar patents RU2782384C2

Title Year Author Number
NANOPARTICLES FOR USE FOR TREATMENT OF NEUROLOGICAL DISORDER 2018
  • Meyre, Marie-Edith
  • Levy, Laurent
  • Pottier, Agnes
RU2779758C2
RESTORATION OF THE SENSORIMOTOR FUNCTION USING A NEUROPROSTHETIC SYSTEM AND METHOD FOR IMPLEMENTATION THEREOF 2020
  • Lavrov Igor Alexandrovich
  • Talanov Maxim Olegovich
  • Toshchev Aleksandr Sergeevich
  • Kuptsov Andrey Pavlovich
RU2772637C2
USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) 2017
  • Kerkis, Irina
  • Valverde Ventseslau, Kristian
RU2742828C2
PEPTIDE CONJUGATED PARTICLES 2014
  • Shea, Lonnie D
  • Miller, Stephen D.
  • Yap, Jonathan Woon Teck
  • Getts, Daniel R.
  • Mccarthy, Derrick
RU2685186C2
FERRITIN NANOPARTICLES CONTAINING CHEMOTHERAPEUTIC AGENT 2019
  • Mazzucchelli, Serena
  • Corsi, Fabio
  • Truffi, Marta
  • Prosperi, Davide
  • Colombo, Miriam
  • Bellini, Michela
RU2810594C2
PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS 2004
  • Kkhan Firdos Alam
  • Totej Satish Makhadeorao
RU2380410C2
STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS, COMPOSITIONS THEREOF AND METHODS OF PRODUCING SAID MESENCHYMAL AND NEURONAL MARKERS 2017
  • Kerkis, Irina
  • Valverde Ventseslau, Kristian
RU2741839C2
NON-MEDUCATIONAL METHOD OF TREATMENT OF ADYNAMIC DEPRESSIONS 2022
  • Neliubova Elena Sergeevna
  • Shmilovich Andrei Arkadevich
  • Kolsanov Aleksandr Vladimirovich
RU2801161C1
METHODS AND COMPOSITIONS FOR STABLE IMMUNOTHERAPY 2014
  • Santamariya Pedro
RU2696876C2
COMPOSITIONS AND METHODS FOR IMPROVEMENT OF VISUAL FUNCTION 2018
  • Isacoff, Ehud Y.
RU2787071C2

RU 2 782 384 C2

Authors

Pottier, Agnes

Levy, Laurent

Meyre, Marie-Edith

Dates

2022-10-26Published

2018-12-18Filed